Results 61 to 70 of about 2,107,233 (243)
Open issues and next challenges in transcatheter mitral valve intervention [PDF]
, 2017 New transcatheter techniques have been recently developed to treat mitral regurgitation with less invasive approaches in high risk and elderly patients. This research is concentrated on the definition of the optimal candidate or optimal approach for some
Taramasso, Maurizio
core +1 more source
Early Experience With Evoque Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Tricuspid regurgitation (TR) is nearly universal in carcinoid heart disease (CHD), but surgical replacement carries significant risk, and CHD was excluded from the landmark TRISCEND II trial. We present seven patients with CHD undergoing Evoque transcatheter tricuspid valve replacement (TTVR) at two tertiary centers.
Jackson S. Burton +3 more
wiley +1 more source
Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma [PDF]
, 2011 Background/Aims: To evaluate the efficacy of multimodality treatment consisting of conventional transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in patients with non-resectable and non-ablatable hepatocellular carcinoma ...
Rentsch, M. +15 more
core +1 more source
Transcatheter Tricuspid Interventions: Past, Present, and Future
Methodist DeBakey Cardiovascular Journal, 2023 Tricuspid regurgitation (TR) etiologies include primary valve pathology or secondary (functional) regurgitation from increased hemodynamic pressure or volume on the right side of the heart. Patients with severe TR have a worse prognosis independent of all other variables.
Colin M. Barker, Kashish Goel
openaire +3 more sources
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT The SAPIEN M3 system has been recently approved for transcatheter mitral valve replacement (TMVR). The transeptal guide sheath is used to deploy the dock, which is completely released before inserting and deploying the M3 valve using the same femoral access, transeptal puncture (TSP) and guide sheath.
Clara Fernandez‐Cordon +5 more
wiley +1 more source
Amplatzer device closure of an inferior venosus atrial septal defect after surgical closure of a secundum atrial septal defect [PDF]
, 2004 This article presents a patient who had transcatheter closure of a low atrial septal defect which was overlooked during surgical closure of a secundum atrial septal defect.
DeGiovanni, Joseph V. +2 more
core
, 2014 Patients with severe aortic stenosis are sometimes not candidates for conventional open heart surgery because of severe deconditioning, excessive risk factors, and multiple comorbidities.
Ioannis M. Panayiotides +2 more
core +1 more source
Transcatheter Tricuspid Valve Therapy: From Anatomy to Intervention [PDF]
, 2021 Nowadays, severe symptomatic tricuspid regurgitation (TR) affects millions of persons worldwide. However, the benefit of surgical correction of isolated secondary TR remains controversial because of the increased risk of periprocedural mortality and ...
Maria Caterina Bono +11 more
core +1 more source
Reviews in Cardiovascular Medicine, 2023 Tricuspid regurgitation (TR) may occur late after left-sided valve surgery (LSVS). Isolated tricuspid regurgitation after left-sided valve surgery (iTR-LSVS) refers to isolated TR without significant lesions in the mitral and/or aortic position late ...
Jinmiao Chen +28 more
doaj +1 more source
The Triple Wire Dual Angioseal Technique for Large Bore Femoral Access Closure
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT There is a growing need for large‐bore femoral access across cardiac interventions. This has led to a need for more widely accessible vascular closure techniques to facilitate reliable vascular closure and wider access to these interventions.
Hilal Khan, Mohaned Egred
wiley +1 more source